New Mexico Department of Health
Meaningful Use Stage 3 Readiness effective January 1, 2018
The New Mexico Department of Health (NMDOH) is accepting the following for
providers who are attesting to Meaningful Use Stage 3 beginning January 1,
2018. More information on Stage 3 reporting is available at:
https://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/
Immunization Reporting
Immunization Reporting readiness for Meaningful Use Stage 3 is currently in place at NMDOH.
Please note revalidation may be necessary upon implementing an update to or a new CEHRT.
The NMDOH Immunization Program has published the local implementation guide for sending immunization data to the New Mexico Statewide
Immunization Information System (NMSIIS). Information is available by clicking here.
NMSIIS accepts HL7 2.5.1 messages that meet the requirements specified in the published guide.
Electronic Laboratory Reporting
Electronic Laboratory Reporting (ELR) readiness for Meaningful Use Stage 3 is currently in
place at NMDOH. Please note revalidation may be necessary upon implementing an update to or a new CEHRT.
To send data to NMDOH laboratories and hospitals must follow the HL7 Version
2.5.1 Implementation Guide: Electronic Laboratory Reporting to Public Health, Release 1 (US Realm), available at
www.cdc.gov/phin/resources/phinguides.html.
Laboratories and hospitals only send results for reportable conditions.
The facility must use current LOIN values when submitting resulted test codes. Current LOINCs available at
http://www.loinc.org/.
Per the state administrative code, http://164.64.110.239/nmac/parts/title07/07.004.0003.htm,
New Mexico is a ‘dual use’ state. This means all laboratories and healthcare professionals must report notifiable conditions to NMDOH. If possible, use an ELR feed to submit
all reportable conditions regardless of testing location, in-house or not.
Syndromic Surveillance
Syndromic Surveillance Reporting readiness for Meaningful Use Stage 3 is currently in
place at NMDOH. Please note revalidation may be necessary upon implementing an update to or a new CEHRT.
Meaningful Use Stage 3 limits Syndromic Surveillance Reporting to emergency departments and urgent care settings. If you have any questions regarding the types of
practitioners that the NMDOH is interested in for onboarding, send an inquiry to syndromic.surveillance@state.nm.us
Providers wanting to send data to the NMDOH must follow the PHIN Messaging Guide for Syndromic Surveillance at
http://www.cdc.gov/phin/resources/phinguides.html.
The NMDOH accepts HL7 version 2.5.1 for message types of A01, A03, A04 and A08.
Electronic Case Reporting
Currently Electronic Case Reporting for Meaningful Use Stage 3 is not available at NMDOH.
NMDOH will update this page when it becomes available.